Top Markets
#1 DeFiChain DeFiChain +1,198.24%
#2 Superfortune Superfortune +102.53%
#3 The Black Bull The Black Bull +88.66%
#4 V.I.T.R.I.O.L. Network V.I.T.R.I.O.L. Network +82.96%
#5 Alien Worlds Alien Worlds +73.06%
#6 Metaplex Metaplex +71.68%
#7 TokenOS AI TokenOS AI +63.39%
#8 Nexus Nexus +53.26%
#9 Magma Finance Magma Finance +44.02%
#10 Hamster Kombat Hamster Kombat +32.59%
Coin of the day
DeFiChain DeFiChain
Settings
Language
ENGLISH
Currency
USD
Theme
Virbac SA Virbac SA

Virbac SA

VIRP
Rank in Stocks #3592
Virbac SA manufactures and sells a range of products and services for companion... Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Share Price
$393.80
Market Cap
$3.30B
Change (1 day)
0.15%
Change (1 year)
4.67%
Country
FR
Trade Virbac SA (VIRP)

Category

Healthcare
Stock split history for Virbac SA (VIRP)
Virbac SA stock (symbol: VIRP) underwent a total of 1 stock splits.
The most recent stock split occurred on Jul 30, 2002.
One VIRP share bought prior to Jul 30, 2002 would equal to 4 VIRP shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2002-07-30 4:1 x4 x4
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 2 x2
CH